维普期刊资源整合服务平台（V6.5）

91篇 您的检索式：作者名="Thor D"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	c-erbB-2 in breast cancer:development of a clinically useful marker显示文摘	Hayes D F Thor A D	2002	Semin Oncol2002，29，3：	1
2	c-erbB-2 in breast cancer:development of a clinically useful marker显示文摘	Thor Ann D	2002	Semin Oncol2002，29，3：	1
3	Cytotoxic T cells invest显示文摘	Andersen MH Schrama D Thor Straten P	2006	Dermatol2006，126，1：	1
4	BCG immunotherapy of bladder cancer: inhibition of tumor recurrence and associated immune responses显示文摘	Lamm D L Thor D E Winters W D	1981	Cancer1981，48，1：	1
5	In vitro evaluation of human cytochrome P450 and P-glycoprotein-mediated metabolism of some phytochemicals in extracts and formulations of African potato 显示文摘	Nair V D Foster B C Thor A J	2007	Phytomedicine2007，14，78：	1
6	c-erbB-2 in breast cancer:development of a clinically useful marker显示文摘	Hayes D F Thor A D	2002	Semin Oncol2002，29，3：	1
7	Cytotoxic T cells in- vest显示文摘	Andersen MH Schrama D Thor Straten P	2006	Dermatol2006，126，1：	1
8	Thor, Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53显示文摘	Mungamuri S K Yang X Thor A D	2006	Cancer Res2006，66，：	1
9	C-erbB-2 in breast cancer development of a clinically useful marker显示文摘	Hayes D F Thor AD	2002	Semin Oncol2002，29，：	1
10	HER-2/neu and p53expression versus tamoxifen resistance in estrogen receptor positive, node-positive breast cancer 显示文摘	Muss H B Thor A D	2000	J Clin Oncol2000，18，：	1
11	c-erbB-2 in breast cancer:development of a clinically useful marker显示文摘	Thor Ann D	2002	Semin Oncol2002，29，3：	1
12	Low dose chronic Schistosoraa mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice 显示文摘	Ellas D Akuffo H Thors C	2005	Clin Exp lmmunol2005，139，3：	1
13	Cytotoxic T cells 显示文摘	Andersen M H Schrama D Thor Stratcn P	2006	J Invest Derrnatol2006，126，1：	1
14	Recombination in avi-an gamma-coronavirus infectious bronchitis virus显示文摘	Thor S W* Hilt D A Kissinger J C	2011	Viruses2011，3，9：	1
15	Cytotoxic Tcells显示文摘	Andersen MH Schrama D Thor Straten P	2006	J Invest Dermatol2006，126，1：	1
16	The overexpression of RHAMM,a hyaluronan-binding protein that regulates ras signaling,correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression显示文摘	Wang C Thor A D Moore D H	1998	Clin Cancer Res1998，4，3：	1
17	Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer显示文摘	LAMM D L THOR D E HARRIS S C	1980	J Urol1980，124，：	1
18	HER-2/neu and p53 ex- pression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer 显示文摘	Berry D A Muss H B Thor A D	2000	J Clin Oncol2000，18，20：	1
19	ErbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer 显示文摘	Berry D A Budman D R	1998	J Natl Cancer Inst1998，90，：	1
20	c-erB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer 显示文摘	Thor A D Berry D A	1994	N Engl J Med1994，330，：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示